SMAD4 clue to colon cancer

Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States.

Reporting last month in the journal Cellular and Molecular Gastroenterology and Hepatology, Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.

SMAD4 is part of the transforming growth factor beta (TGF-beta) signaling pathway that in the epithelium of the colon regulates the immune/inflammatory response to infection.

Specific deletion of the Smad4gene in normal mouse colon epithelial cells grown in vivo increased the expression of inflammatory mediators. In adult mice in the presence of inflammation, deletion resulted in tumors bearing a striking resemblance to human colitis-associated carcinoma.

Loss of SMAD4 also was observed in 48 percent of human colitis-associated carcinomas compared with 19 percent of sporadic colorectal carcinomas. "This loss may be an important factor in progression from to invasive malignancy," the researchers concluded.


Explore further

Colon signaling pathway key to inflammatory bowel disease

More information: Anna L. Means et al. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer, Cellular and Molecular Gastroenterology and Hepatology (2018). DOI: 10.1016/j.jcmgh.2018.05.006
Provided by Vanderbilt University
Citation: SMAD4 clue to colon cancer (2018, July 6) retrieved 16 February 2019 from https://medicalxpress.com/news/2018-07-smad4-clue-colon-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more